| Xpert MTB/RIF results in patients with previous tuberculosis: can we distinguish true from false positive results? G Theron, R Venter, G Calligaro, L Smith, J Limberis, R Meldau, ... Clinical Infectious Diseases 62 (8), 995-1001, 2016 | 172 | 2016 |
| Outcomes, infectiousness, and transmission dynamics of patients with extensively drug-resistant tuberculosis and home-discharged patients with programmatically incurable … K Dheda, JD Limberis, E Pietersen, J Phelan, A Esmail, M Lesosky, ... The lancet Respiratory medicine 5 (4), 269-281, 2017 | 155 | 2017 |
| Determinants of PCR performance (Xpert MTB/RIF), including bacterial load and inhibition, for TB diagnosis using specimens from different body compartments G Theron, J Peter, G Calligaro, R Meldau, C Hanrahan, H Khalfey, ... Scientific reports 4 (1), 5658, 2014 | 152 | 2014 |
| False-positive Xpert MTB/RIF results in retested patients with previous tuberculosis: frequency, profile, and prospective clinical outcomes G Theron, R Venter, L Smith, A Esmail, P Randall, V Sood, S Oelfese, ... Journal of clinical microbiology 56 (3), 10.1128/jcm. 01696-17, 2018 | 114 | 2018 |
| Effect of new tuberculosis diagnostic technologies on community-based intensified case finding: a multicentre randomised controlled trial GL Calligaro, LS Zijenah, JG Peter, G Theron, V Buser, R McNerney, ... The Lancet Infectious Diseases 17 (4), 441-450, 2017 | 92 | 2017 |
| Removing the bottleneck in whole genome sequencing of Mycobacterium tuberculosis for rapid drug resistance analysis: a call to action R McNerney, TG Clark, S Campino, C Rodrigues, D Dolinger, L Smith, ... International Journal of Infectious Diseases 56, 130-135, 2017 | 80 | 2017 |
| Deletion of IL-4 Receptor Alpha on Dendritic Cells Renders BALB/c Mice Hypersusceptible to Leishmania major Infection R Hurdayal, NE Nieuwenhuizen, M Revaz-Breton, L Smith, JC Hoving, ... PLoS pathogens 9 (10), e1003699, 2013 | 64 | 2013 |
| Bacterial and host determinants of cough aerosol culture positivity in patients with drug-resistant versus drug-susceptible tuberculosis G Theron, J Limberis, R Venter, L Smith, E Pietersen, A Esmail, ... Nature medicine 26 (9), 1435-1443, 2020 | 56 | 2020 |
| Determinants of PCR performance (Xpert MTB/RIF), including bacterial load and inhibition, for TB diagnosis using specimens from different body compartments. Sci Rep. 2014; 4: 5658 G Theron, J Peter, G Calligaro, R Meldau, C Hanrahan, H Khalfey, ... | 20 | |
| The frequency and effect of granulocytic myeloid-derived suppressor cells on mycobacterial survival in patients with tuberculosis: A preliminary report M Davids, A Pooran, L Smith, M Tomasicchio, K Dheda Frontiers in immunology 12, 676679, 2021 | 13 | 2021 |
| The Injectable Contraceptive Medroxyprogesterone Acetate Attenuates Mycobacterium tuberculosis–Specific Host Immunity Through the Glucocorticoid Receptor M Tomasicchio, M Davids, A Pooran, G Theron, L Smith, L Semple, ... The Journal of infectious diseases 219 (8), 1329-1337, 2019 | 9 | 2019 |
| Antimycobacterial activity and molecular docking of methanolic extracts and compounds of marine fungi from Saldanha and False Bays, South Africa KI Tapfuma, K Nyambo, F Adu-Amankwaah, L Baatjies, L Smith, N Allie, ... Heliyon 8 (12), 2022 | 8 | 2022 |
| Molecular docking, molecular dynamics simulations and binding free energy studies of interactions between Mycobacterium tuberculosis Pks13, PknG and … K Nyambo, KI Tapfuma, F Adu-Amankwaah, L Julius, L Baatjies, IS Niang, ... Scientific Reports 14 (1), 6794, 2024 | 6 | 2024 |
| Fungal-derived compounds and mycogenic nanoparticles with antimycobacterial activity: a review KI Tapfuma, K Nyambo, L Baatjies, M Keyster, L Mekuto, L Smith, N Allie, ... SN Applied Sciences 4 (5), 134, 2022 | 4 | 2022 |
| In-silico and in-vitro assessments of some fabaceae, rhamnaceae, apocynaceae, and anacardiaceae species against Mycobacterium tuberculosis H37Rv and … K Nyambo, F Adu-Amankwaah, KI Tapfuma, L Baatjies, L Julius, L Smith, ... BMC Complementary Medicine and Therapies 23 (1), 219, 2023 | 2 | 2023 |
| Frequency and clinical profile of false positive Xpert MTB/RIF results in patients previously treated for tuberculosis G Theron, R Venter, L Smith, GL Calligaro, A Esmail, RM Warren, ... A26. DIAGNOSIS AND TREATMENT OF TUBERCULOSIS, A1171-A1171, 2017 | 1 | 2017 |
| Bacterial And Host Determinants Of Infectiousness In Patients With Drug-Susceptible Or Drug-Resistant Tuberculosis G Theron, L Smith, JD Limberis, R Venter, A Esmail, R McNerney, ... D96. INFECTIOUSNESS AND TRANSMISSION OF TUBERCULOSIS, A7319-A7319, 2017 | | 2017 |
| The Injectable Contraceptive Medroxyprogesterone Acetate Decreases Peripheral Effector Cell-Mediated Mycobacterium Tuberculosis Containment Through Immunosuppression Involving … M Tomasicchio, G Theron, M Davids, AS Pooran, L Smith, L Semple, ... B17. MYCOBACTERIAL HOST DEFENSES, A2905-A2905, 2017 | | 2017 |
| A26 DIAGNOSIS AND TREATMENT OF TUBERCULOSIS: Frequency And Clinical Profile Of False Positive Xpert Mtb/rif Results In Patients Previously Treated For Tuberculosis G Theron, R Venter, L Smith, GL Calligaro, A Esmail, RM Warren, ... American Journal of Respiratory and Critical Care Medicine 195, 2017 | | 2017 |
| D96 INFECTIOUSNESS AND TRANSMISSION OF TUBERCULOSIS: Bacterial And Host Determinants Of Infectiousness In Patients With Drug-Susceptible Or Drug-Resistant Tuberculosis G Theron, L Smith, JD Limberis, R Venter, A Esmail, R McNerney, ... American Journal of Respiratory and Critical Care Medicine 195, 2017 | | 2017 |
